Skip to menu Skip to content Skip to footer

2008

Conference Publication

Anterior dominant prostate cancer compared with posterior cancers in a PSA non-screened population

Samaratunga, H., Delahunt, B., Duffy, D. and Yaxley, J. (2008). Anterior dominant prostate cancer compared with posterior cancers in a PSA non-screened population. 97th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Denver Co, Mar 01-07, 2008. NEW YORK: NATURE PUBLISHING GROUP.

Anterior dominant prostate cancer compared with posterior cancers in a PSA non-screened population

2008

Journal Article

Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer

Kelly Anne Landers, Samaratunga, Hemamali, Linda Teng, Buck, M., Burger, Michelle J., Betty Scells, Lavin, Martin F. and Gardiner, Robert A. (2008). Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer. British Journal of Cancer, 99 (3), 491-501. doi: 10.1038/sj.bjc.6604486

Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer

2008

Conference Publication

Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs)

Ramsay, Andrew J., Reid, Janet C., Adams, Mark N., Samaratunga, Hemamali, Dong, Ying, Clements, Judith A. and Hooper, John D. (2008). Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs). 2nd International Symposium on Kallikrein and Kallikrein-Related Peptidases (ISK 2007), Santorini, Greece, 16-18 October 2007. Berlin, Germany: Walter de Gruyter. doi: 10.1515/BC.2008.078

Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs)

2007

Journal Article

Prostatic ductal adenocarcinoma presenting as a urethral polyp: a clinicopathological study of eight cases of a lesion with the potential to be misdiagnosed as a benign prostatic urethral polyp

Samaratunga, Hemamali and Letizia, Bernadette (2007). Prostatic ductal adenocarcinoma presenting as a urethral polyp: a clinicopathological study of eight cases of a lesion with the potential to be misdiagnosed as a benign prostatic urethral polyp. Pathology, 39 (5), 476-481. doi: 10.1080/00313020701570004

Prostatic ductal adenocarcinoma presenting as a urethral polyp: a clinicopathological study of eight cases of a lesion with the potential to be misdiagnosed as a benign prostatic urethral polyp

2007

Journal Article

Significance of minute focus of adenocarcinoma on prostate needle biopsy

Samaratunga, Hemamali, Yaxley, John, Kerr, Kris, McClymont, Kelly and Duffy, David (2007). Significance of minute focus of adenocarcinoma on prostate needle biopsy. Urology, 70 (2), 299-302. doi: 10.1016/j.urology.2007.03.068

Significance of minute focus of adenocarcinoma on prostate needle biopsy

2007

Journal Article

A working group classification of focal prostate atrophy lesions. (vol 30, pg 1281, 2006)

De Marzo, A. M., Platz, E. A., Epstein, J., Ali, T., Billis, A., Chan, T. Y., Cheng, L., Datta, M., Egevad, L., Ertoy-Baydar, D., Farre, X., Fine, S. W., Iczkowski, K. A., Ittmann, M., Knudsen, B. S., Loda, M., Lopez-Beltran, A., Magi-Galluzzi, C., Mikuz, G., Montironi, R., Pikarsky, E., Pizov, G., Rubin, M. A., Samaratunga, H., Sebo, T., Sesterhenn, I. A., Shah, R. B., Signoretti, S., Simko, J. ... Lucia, M. S. (2007). A working group classification of focal prostate atrophy lesions. (vol 30, pg 1281, 2006). American Journal of Surgical Pathology, 31 (4), 652-652.

A working group classification of focal prostate atrophy lesions. (vol 30, pg 1281, 2006)

2007

Conference Publication

Multiple molecular markers in the diagnosis of prostate cancer from prostatic fluid

Gardiner, R. A., Burger, M. J., Landers, K. A., Roper, K., Scells, B., Samaratunga, M. L. T. H., Yaxley, J., Stening, S. and Lavin, M. F. (2007). Multiple molecular markers in the diagnosis of prostate cancer from prostatic fluid. Urological Society of Australia and New Zealand 60th Annual Scientific Meeting, Adelaide, Australia, 18-22 February 2007. London, UK: Blackwell Science. doi: 10.1111/j.1464-410X.2007.06719.x

Multiple molecular markers in the diagnosis of prostate cancer from prostatic fluid

2006

Journal Article

A working group classification of focal prostate atrophy lesions (vol 30, pg 1281, 2006)

De Marzo, A. M., Platz, E. A., Epstein, J., Ali, T., Billis, A., Chan, T. Y., Cheng, L., Datta, M., Egevad, L., Ertoy-Baydar, D., Farree, X., Fine, S. W., Iczkowski, K. A., Ittmann, M., Knudsen, B. S., Loda, M., Lopez-Beltran, A., Magi-Galluzzi, C., Mikuz, G., Montironi, R., Pikarsky, E., Pizov, G., Rubin, M. A., Samaratunga, H., Sebo, T., Sesterhenn, I. A., Shah, R. B., Signoretti, S., Simko, J. ... Lucia, M. S. (2006). A working group classification of focal prostate atrophy lesions (vol 30, pg 1281, 2006). American Journal of Surgical Pathology, 30 (11), 1489-1489.

A working group classification of focal prostate atrophy lesions (vol 30, pg 1281, 2006)

2006

Journal Article

Atypical prostatic glandular proliferations on needle biopsy - Diagnostic implications, use of immunohistochemistry, and clinical significance

Samaratunga, H., Gardiner, R.A., Yaxley, J. and Brown, I. (2006). Atypical prostatic glandular proliferations on needle biopsy - Diagnostic implications, use of immunohistochemistry, and clinical significance. Analytical And Quantitative Cytology And Histology, 28 (2), 104-110.

Atypical prostatic glandular proliferations on needle biopsy - Diagnostic implications, use of immunohistochemistry, and clinical significance

2006

Conference Publication

Positive margin rates in patients with a single positive core on extended TRUS biopsy

Dangerfield, D., Samaratunga, H. and Yaxley, J. (2006). Positive margin rates in patients with a single positive core on extended TRUS biopsy. The Urological Society of Australasia Annual Scientific Meeting 2006, Brisbane, QLD Australia, 26-30 March 2006. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

Positive margin rates in patients with a single positive core on extended TRUS biopsy

2006

Conference Publication

The significance of finding a small focus of prostatic adenocarcinoma on needle biopsy

Samaratunga, H, Yaxley, J, Kerr, K and McClymont, K (2006). The significance of finding a small focus of prostatic adenocarcinoma on needle biopsy. 95th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Atlanta, Georgia, 11-17 February 2006 . London, United Kingdom: Nature Publishing Group.

The significance of finding a small focus of prostatic adenocarcinoma on needle biopsy

2006

Journal Article

A working group classification of focal prostate atrophy lesions

De Marzo A.M., Platz E.A., Epstein J.I., Ali T., Billis A., Chan T.Y., Cheng L., Datta M., Egevad L., Ertoy-Baydar D., Farree X., Fine S.W., Iczkowski K.A., Ittmann M., Knudsen B.S., Loda M., Lopez-Beltran A., Magi-Galluzzi C., Mikuz G., Montironi R., Pikarsky E., Pizov G., Rubin M.A., Samaratunga H., Sebo T., Sesterhenn I.A., Shah R.B., Signoretti S., Simko J. ... Lucia M.S. (2006). A working group classification of focal prostate atrophy lesions. American Journal of Surgical Pathology, 30 (10), 1281-1291. doi: 10.1097/01.pas.0000213289.50660.be

A working group classification of focal prostate atrophy lesions

2005

Journal Article

Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms

Dong, Y., Bui, L. T., Odorico, D. M., Tan, O. L., Myers, S. A., Samaratunga, H., Gardiner, R. A. and Clements, J. A. (2005). Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms. Endocrine-Related Cancer, 12 (4), 875-889. doi: 10.1677/erc.1.01062

Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms

2005

Journal Article

Significance of stromal reaction patterns in invasive urothelial carcinoma

Samaratunga, H, Fairweather, P and Purdie, D (2005). Significance of stromal reaction patterns in invasive urothelial carcinoma. American Journal of Clinical Pathology, 123 (6), 851-857. doi: 10.1309/EE8RTB6X611G6TU

Significance of stromal reaction patterns in invasive urothelial carcinoma

2005

Journal Article

Use of multiple biomarkers for a molecular diagnosis of prostate cancer

Landers, Kelly A., Burger, Michelle J., Tebay, Michelle A., Purdie, David M., Scells, Betty, Samaratunga, Hemamali, Lavin, Martin F. and Gardiner, Robert A. (2005). Use of multiple biomarkers for a molecular diagnosis of prostate cancer. International Journal of Cancer, 114 (6), 950-956. doi: 10.1002/ijc.20760

Use of multiple biomarkers for a molecular diagnosis of prostate cancer

2005

Conference Publication

Claudin 4: a new therapeutic target for prostate cancer?

Gardiner, RA, Landers, KA, Burger, MJ, Scells, B, Samaratunga, MLTH and Lavin, MF (2005). Claudin 4: a new therapeutic target for prostate cancer?. Annual Scientific Meeting of the Urological- Society-of-Australasia, Melbourne Australia, Feb 13-17, 2005. OXFORD: BLACKWELL PUBLISHING.

Claudin 4: a new therapeutic target for prostate cancer?

2005

Conference Publication

Prostatic adenocarcinoma with mucinous components a clinicopathological and immunohistochemical study

Samaratunga, H. and Brown, I. (2005). Prostatic adenocarcinoma with mucinous components a clinicopathological and immunohistochemical study. 94th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, San Antonio, TX, United States, 26 February - 4 March 2005. Amsterdam, Netherlands: Elsevier.

Prostatic adenocarcinoma with mucinous components a clinicopathological and immunohistochemical study

2004

Journal Article

Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study

Samaratunga, H and Khoo, K (2004). Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study. Histopathology, 45 (1), 55-64. doi: 10.1111/j.1365-2559.2004.01895.x

Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study

2004

Journal Article

Expression of the disintegrin metalloprotease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I, and epidermal growth factor in the prostate cancer cell model LNCaP

McCulloch, Daniel R, Akl, Pascal, Samaratunga, Hemamali, Herington, Adrian C. and Odorico, Dimitri M. (2004). Expression of the disintegrin metalloprotease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I, and epidermal growth factor in the prostate cancer cell model LNCaP. Clinical Cancer Research, 10 (1), 314-323. doi: 10.1158/1078-0432.CCR-0846-3

Expression of the disintegrin metalloprotease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I, and epidermal growth factor in the prostate cancer cell model LNCaP

2003

Conference Publication

Micropapillary variant of urothelial carcinoma of the urinary bladder: Clinicopathological and immunohistochemical study

Samaratunga, H and Khoo, K (2003). Micropapillary variant of urothelial carcinoma of the urinary bladder: Clinicopathological and immunohistochemical study. 92nd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Washington D.C., Mar 22-28, 2003. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Micropapillary variant of urothelial carcinoma of the urinary bladder: Clinicopathological and immunohistochemical study